Rationale for the Pediatric Hematology and Transfusion Medicine Multidisciplinary Research Training Award (PHTMMRT) at Children?s National

国家儿童医院儿科血液学和输血医学多学科研究培训奖 (PHTMMRT) 的理由

基本信息

  • 批准号:
    10360585
  • 负责人:
  • 金额:
    $ 12.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-02-01 至 2024-01-31
  • 项目状态:
    已结题

项目摘要

The rationale for this renewal application is to continue our highly collaborative and multidisciplinary, inter- institutional program of mentored training for future scientists in pediatric transfusion medicine and hematology. Our objective is to address the barriers for the conduct of high quality and transformative research in pediatric transfusion medicine and hematology including: 1) lack of a robust infrastructure for research training and implementation; 2) shortage of mid-career and senior investigators to serve as research mentors; 3) need for multidisciplinary translational approaches to answer critical clinical questions; 4) lack of diversity among clinical and translational investigators. This program is focused on advancing clinical and translational scholarship on the diagnosis and clinical management of hematological, cardiovascular and pulmonary disorders, transfusion, cell therapy and transplantation. The design of the Pediatric Hematology and Transfusion Medicine Multidisciplinary Research Training Award (PHTMMRT) is focused on preparing trainees from diverse backgrounds for academic leadership and independently funded research careers. Each trainee in the program completes a Master's in Clinical and Translational Science (MsCTR) at the George Washington University (GWU) School of Medicine and Health Sciences or equivalent, and will devise, implement and complete a research project under the joint oversight of a multidisciplinary mentorship team. At the completion of the two- to three-year program, each trainee will have presented his/her data to at least one national research meeting, drafted and submitted one or more manuscripts suitable for external peer-reviewed publications, and for those in a three-year program, submitted an external grant application to the NIH or equivalent funding source. The program is overseen by two NIH-funded Principal Investigators with complementary clinical and research expertise, supported by nine faculty of Children's National and GWU, with four external mentors. All mentors are research scientists with expertise in coagulation, transfusion medicine, cell therapy, transplantation, vascular biology and genomic/proteomics. A Diversity Enhancement Officer will assist in the recruitment of minority, disabled or disadvantaged applicants, and women. Finally, an External Advisory Committee of four NIH-funded national leaders in transfusion medicine, transplantation and hematology with established career mentorship programs will offer annual feedback and guidance of the PHTMMRT program and the trainees' progress. The PHTMMRT program will leverage several of Children's National's multiple and pre-existing strengths with collaborating neighboring research institutions including the NIH, GWU and Howard University School of Medicine (HUSM). In summary, our multidisciplinary, inter-institutional mentors will train four to five future academic leaders in Pediatric Hematology/Transfusion Medicine including a focus on cell-based therapies for heart, lung and blood diseases.
此次续签申请的理由是继续我们的高度协作和多学科、跨领域合作。 为儿科输血医学和血液学领域的未来科学家提供指导培训的机构计划。 我们的目标是消除儿科领域进行高质量和变革性研究的障碍 输血医学和血液学包括:1)缺乏强大的研究培训基础设施和 执行; 2)缺乏担任研究导师的中高级研究人员; 3)需要 多学科转化方法来回答关键的临床问题; 4)临床缺乏多样性 和转化研究者。该计划的重点是推进临床和转化奖学金 血液学、心血管和肺部疾病、输血、 细胞治疗和移植。小儿血液学与输血医学科的设计 多学科研究培训奖(PHTMMRT)专注于培养来自不同领域的学员 学术领导和独立资助的研究生涯的背景。项目中的每位学员 在乔治华盛顿大学完成临床和转化科学硕士学位 (MsCTR) (GWU)医学与健康科学学院或同等机构,并将设计、实施和完成 在多学科导师团队的联合监督下进行的研究项目。完成两件事后—— 在三年计划中,每位学员将向至少一次全国研究会议展示他/她的数据, 起草并提交了一份或多份适合外部同行评审出版物的手稿,以及 在一项为期三年的计划中,向 NIH 或同等资金来源提交了外部资助申请。这 该计划由两名 NIH 资助的首席研究员监督,具有互补的临床和研究 专业知识,由国家儿童医院和乔治华盛顿大学的九名教师以及四名外部导师的支持。所有导师 是在凝血、输血医学、细胞治疗、移植、 血管生物学和基因组/蛋白质组学。多元化增强官员将协助招聘 少数族裔、残疾人或弱势申请人以及妇女。最后,由四人组成的外部咨询委员会 美国国立卫生研究院 (NIH) 资助的输血医学、移植和血液学领域的国家领导人,拥有成熟的职业生涯 导师计划将提供 PHTMMRT 计划和学员的年度反馈和指导 进步。 PHTMMRT 计划将利用国家儿童基金会的多个和已有的项目 与 NIH、GWU 和霍华德大学等邻近研究机构的合作优势 医学院(HUSM)。总之,我们的多学科、跨机构导师将培训四到五名 儿科血液学/输血医学的未来学术领导者,包括关注基于细胞的 治疗心脏、肺和血液疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Catherine M. Bollard其他文献

The IPTA Nashville consensus conference on post-transplant lymphoproliferative disorders after solid organ transplantation in children: IV-consensus guidelines for the management of post-transplant lymphoproliferative disorders in children and adolescents.
关于儿童实体器官移植后移植后淋巴细胞增殖性疾病的 IPTA 纳什维尔共识会议:儿童和青少年移植后淋巴细胞增殖性疾病管理 IV 共识指南。
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    1.3
  • 作者:
    Upton D Allen;A. L'Huillier;Catherine M. Bollard;Thomas G Gross;Robert J. Hayashi;B. Höcker;Brtitta Maecker;Stephen D Marks;George V Mazariegos;Françoise Smets;Ralf U Trappe;Gary A. Visner;R. Chinnock;Patrizia Comoli;L. Danziger;Daniel E Dulek;A. Dipchand;Judith A Ferry;Olivia M. Martinez;Diana M Metes;Marian G. Michaels;Jutta Preiksaitis;James E Squires;S. Swerdlow;James D Wilkinson;V. Dharnidharka;Michael Green;Steven A. Webber;Carlos O. Esquivel
  • 通讯作者:
    Carlos O. Esquivel
PR1-specificcytotoxic T lymphocytes are relatively frequent in umbilical cord blood and canbe effectively expanded to target myeloid leukemia
PR1特异性细胞毒性T淋巴细胞在脐带血中相对常见,可有效扩增以靶向髓系白血病
  • DOI:
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    4.5
  • 作者:
    Lisa S.St. John;Liping Wan;Hong He;Haven R. Garber;Karen Clise-Dwyer;Gheath Alatrash;Katyoun Rezvani;Elizabeth J.Shpall;Catherine M. Bollard;Qing Ma;Jeffrey J. Molldrem
  • 通讯作者:
    Jeffrey J. Molldrem
Pediatric Burkitt's Lymphoma and Diffuse B-Cell Lymphoma: Are Surveillance Scans Required?
儿童伯基特淋巴瘤和弥漫性 B 细胞淋巴瘤:是否需要监测扫描?
  • DOI:
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    1.7
  • 作者:
    Hesham M Eissa;Hesham M Eissa;Carl E. Allen;Carl E. Allen;K. Kamdar;K. Kamdar;Stephen Simko;Stephen Simko;P. Goradia;Z. Dreyer;Z. Dreyer;P. Steuber;P. Steuber;Kenneth L. McClain;Kenneth L. McClain;R. P. Guillerman;Catherine M. Bollard;Catherine M. Bollard
  • 通讯作者:
    Catherine M. Bollard
Photothermal Prussian blue nanoparticles generate potent multi‐targeted tumor‐specific T cells as an adoptive cell therapy
光热普鲁士蓝纳米颗粒可产生有效的多靶点肿瘤特异性 T 细胞作为过继细胞疗法
  • DOI:
    10.1002/btm2.10639
  • 发表时间:
    2023-12-22
  • 期刊:
  • 影响因子:
    7.4
  • 作者:
    E. Sweeney;P. Sekhri;N. Muniraj;Jie Chen;Sally Feng;Joshua Terao;Samantha J. Chin;Danielle E. Schmidt;Catherine M. Bollard;C. Russell Y. Cruz;R. Fern;es;es
  • 通讯作者:
    es
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children’s Oncology Group study
使用利妥昔单抗和第三方 LMP 特异性 T 细胞后对 EBV 产生持久免疫力:一项儿童肿瘤学小组研究
  • DOI:
    10.1182/bloodadvances.2023010832
  • 发表时间:
    2024-01-01
  • 期刊:
  • 影响因子:
    7.5
  • 作者:
    B. Wistinghausen;K. Toner;D. Barkauskas;Lauren P Jerkins;Hannah Kinoshita;Pamela Chansky;Gloria Pezzella;Lauren Saguilig;Robert J Hayashi;H. Abhyankar;B. Scull;Vivekanudeep Karri;J. Tanna;P. Hanley;M. Hermiston;Carl E. Allen;Catherine M. Bollard
  • 通讯作者:
    Catherine M. Bollard

Catherine M. Bollard的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Catherine M. Bollard', 18)}}的其他基金

NextGen - CRI
下一代 - CRI
  • 批准号:
    10627010
  • 财政年份:
    2022
  • 资助金额:
    $ 12.39万
  • 项目类别:
NextGen - CRI
下一代 - CRI
  • 批准号:
    10845777
  • 财政年份:
    2022
  • 资助金额:
    $ 12.39万
  • 项目类别:
NextGen - CRI
下一代 - CRI
  • 批准号:
    10627010
  • 财政年份:
    2022
  • 资助金额:
    $ 12.39万
  • 项目类别:
Cancer Immunotherapy Winter School (CIWS)
癌症免疫治疗冬季学校(CIWS)
  • 批准号:
    10391811
  • 财政年份:
    2022
  • 资助金额:
    $ 12.39万
  • 项目类别:
Antigen Specific T Cells
抗原特异性 T 细胞
  • 批准号:
    10671624
  • 财政年份:
    2019
  • 资助金额:
    $ 12.39万
  • 项目类别:
Antigen Specific T Cells
抗原特异性 T 细胞
  • 批准号:
    10197003
  • 财政年份:
    2019
  • 资助金额:
    $ 12.39万
  • 项目类别:
Enhancing cell therapy for brain tumors
增强脑肿瘤的细胞治疗
  • 批准号:
    10477394
  • 财政年份:
    2018
  • 资助金额:
    $ 12.39万
  • 项目类别:
Enhancing cell therapy for brain tumors
增强脑肿瘤的细胞治疗
  • 批准号:
    10246936
  • 财政年份:
    2018
  • 资助金额:
    $ 12.39万
  • 项目类别:
Enhancing cell therapy for brain tumors
增强脑肿瘤的细胞治疗
  • 批准号:
    9788348
  • 财政年份:
    2018
  • 资助金额:
    $ 12.39万
  • 项目类别:
HIV-specific ex-vivo expanded T cell therapy (HXTC) to Deplete the Latent Reservoir of Persistent HIV Infection
HIV 特异性体外扩增 T 细胞疗法 (HXTC) 可消除持续性 HIV 感染的潜在储库
  • 批准号:
    9889986
  • 财政年份:
    2016
  • 资助金额:
    $ 12.39万
  • 项目类别:

相似海外基金

Implementation Science and Equity
实施科学与公平
  • 批准号:
    10557509
  • 财政年份:
    2023
  • 资助金额:
    $ 12.39万
  • 项目类别:
Sleep health of preschool children in Bangladesh: predictors, role on executive function and obesity, and sleep promotion intervention
孟加拉国学龄前儿童的睡眠健康:预测因素、对执行功能和肥胖的作用以及睡眠促进干预
  • 批准号:
    10805985
  • 财政年份:
    2023
  • 资助金额:
    $ 12.39万
  • 项目类别:
Longitudinal investigation of the relations among stress, brain activity, neurocognitive skill, and socioemotional functioning during infancy
婴儿期压力、大脑活动、神经认知技能和社会情绪功能之间关系的纵向调查
  • 批准号:
    10898118
  • 财政年份:
    2023
  • 资助金额:
    $ 12.39万
  • 项目类别:
Circadian Rhythms in Human Milk Cortisol: An Examination of Maternal and Environmental Regulators
母乳皮质醇的昼夜节律:母体和环境调节剂的检查
  • 批准号:
    10653545
  • 财政年份:
    2023
  • 资助金额:
    $ 12.39万
  • 项目类别:
Development and implementation of a pediatric AI multi-modal digital stethoscope and respiratory surveillance system in South Africa
在南非开发和实施儿科人工智能多模态数字听诊器和呼吸监测系统
  • 批准号:
    10740943
  • 财政年份:
    2023
  • 资助金额:
    $ 12.39万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了